Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
55 results
D2.386 - Quantification of airborne allergens – Comparison between inhalable dust sampling and a new ambient air sampler
D2.387 - Reducing the Carbon Footprint of Cetirizine Prescription: Exploring Patient Perspectives on Formulation Choice in an Allergy Clinic
D2.388 - Greening office spaces: the impact of indoor plants on autonomic nervous system activity
D2.389 - A Dynamic Interaction Between the Immune System, the Exposome, and Climate Change: The Shifting Sensitization Profile to Respiratory Allergens Across Life
D2.390 - Effects of Cigarette Smoke on Expression and Rhythmicity ofr Core Circadian Genes in Peripheral Blood Mononuclear Cells (PBMC) and Bronchial Epithelial Cells
D2.391 - Changing Patterns of Aeroallergen Sensitization in Zagreb: Ragweed as the Predominant Allergen in a Sensitized Adult Population
D2.393 - Balancing Green Initiatives with Public Health: A Framework for Allergy-Friendly Urban Planning
D2.394 - A class-variable immunoglobulin response to birch (B. pendula) pollen allergens
D2.395 - Characterization of Juniperus oxycedrus pollen extract and identification of putative allergens
D2.396 - Evaluating Advanced Fabric Care Technologies for Effective Dust Mite Eradication to Mitigate the Risk of Asthma
D2.397 - Air Pollution and Respiratory Health: A Regression Analysis of Asthma and Upper Respiratory Infections
000766 - Clonal mast cell disorders, allergy to hymenoptera venom and venom immunotherapy – our experience
D1.231 - When Antihistamines Paradoxically Worsen Chronic Spontaneous Urticaria: Trust Your Patient
- D3.117 - Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice
D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data
D3.204 - Elevated Tryptase Levels in a Severe Asthmatic Patient Undergoing SCIT for Birch: Implications for Monitoring and Personalized Treatment
D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases
D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin
D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity
D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis
Pagination
First page
First
Previous page
Previous
Page
1
Current page
2
Page
3
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download